Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

07/02/2020 06:00

Feb 7 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.07               12.23            14.47    
                 (-17.7 pct)         (+6.4 pct)       (-7.6 pct)  
  Operating          1.58              341 mln            2.20    
                (+361.2 pct)                         (+165.1 pct) 
  Recurring          2.14                1.02             3.00    
                (+111.0 pct)                          (+85.9 pct) 
  Net                1.61                1.57             2.10    
                 (+2.6 pct)                           (+7.7 pct)  
  EPS             38.56 yen           37.60 yen        50.44 yen  
  Ann Div                             3.00 yen         5.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T